<DOC>
	<DOCNO>NCT01597063</DOCNO>
	<brief_summary>Pregnant woman low risk indicator fetal chromosomal aneuploidy enrol . Study blood collect first second trimester schedule prenatal screen visit , process plasma , store frozen analysis . Each pregnancy follow delivery birth outcome record .</brief_summary>
	<brief_title>Clinical Evaluation SEQureDx Trisomy Test Low Risk Pregnancies</brief_title>
	<detailed_description />
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<mesh_term>Trisomy</mesh_term>
	<criteria>Pregnancy 1022 week gestation Between 1834 year age inclusive estimate date delivery No prenatal screen indicator high risk include serum biochemical ultrasound screen No personal family history Down syndrome Willing provide write informed consent Willing provide whole blood sample Willing provide access medical record support fetal outcome Fetal demise time blood draw Previous specimen donation protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>34 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>